Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Breast cancer mosaic
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, October 9, 2013

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

Pictured: Pseudomonas aeruginosa
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 1, 2013

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

Pictured: Daniel Thorek & Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, September 25, 2013

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Pictured: Derek Tan
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, September 16, 2013

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

Pictured: Kenneth Offit
In the Lab
By Maureen Salamon, BA, Freelance Writer  |  Monday, September 9, 2013

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

Pictured: Cancer cell lines
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, August 26, 2013

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.

Pictured: Clostridium difficile
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, August 7, 2013

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Pictured: Three-dimensional structure of the protein mTOR
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, May 30, 2013

In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

Pictured:  Timothy Chan
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, May 24, 2013

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

Pictured: Melanocytes
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 14, 2013

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

Pictured: Douglas Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, May 1, 2013

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Pictured: Charles Sawyers
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Center News

Stay Informed

Get the latest information about cancer care and research every month.